Jack Dreyer was placed on the injured list on Sunday with shoulder discomfort, and X-rays taken after the move showed inflammation but no structural damage, the team said. The Dodgers expressed hope he would need only the minimum stint on the IL, a relief in a season already defined by thin pitching margins.
The roster reaction was immediate. After Dreyer's move, Paul Gervase was recalled and Charlie Barnes — who had come up two days earlier to take Blake Snell's place on the roster — was optioned back. The transaction chain is part of a steady churn: Chayce McDermott was recalled and then returned to Triple-A one day later when the Dodgers signed free agent pitcher Jonathan Hernández.
Behind the scenes the club is juggling deeper losses. Ben Casparius was transferred to the 60-day injured list with right shoulder inflammation, and two of the staff’s highest-profile arms were already out. Tyler Glasnow, who has been unavailable after being pulled from a start and later landing on the injured list, offered his customary short, literal update: "Tall Guy Back."
This is not a one-off problem. In recent years the Dodgers used 40 pitchers in back-to-back seasons, a staggering figure that underlines the franchise’s reliance on volume to cover attrition. Starters and relievers have suffered repeated injuries, and the club has repeatedly leaned on short-term recalls, one-day stays and last-minute signings to keep innings available.
The immediate weight of Dreyer's IL move is simple and quantifiable: another arm out, another roster slot to shuffle. The Dodgers recalled Gervase and reversed Barnes’s two-day stay; McDermott’s return to Triple-A a day later when Hernández was signed shows how quickly plans change. Each small move compounds; a single shoulder inflammation can ripple through a pitching staff already stretched thin.
Context matters because the pattern stretches beyond individual ailments. The team’s heavy pitcher usage in recent seasons has created a brittle depth chart. The Dodgers have repeatedly replaced injured starters and relievers, and the result is a season-to-season reliance on newcomers and bullpen overuse. That background explains why a nonstructural shoulder inflammation is treated as more urgent than it might be on paper.
The tension is in the mismatch between public reassurance and roster reality. The club says Dreyer's X-rays showed no structural damage and that they are hopeful he will need only the minimum time on the IL, but they simultaneously shifted pieces in and out of the big-league roster within days. Chayce McDermott’s one-day return to Triple-A after an immediate signing shows the team is operating with trial-and-error urgency rather than a settled contingency plan.
There are practical limits. Moving Gervase up after Dreyer’s IL slot and optioning Barnes two days after he was added to replace Snell are short-term fixes; transferring Casparius to the 60-day injured list buys roster space but signals a longer absence. The Dodgers can keep signing free agents or calling minor-league arms, but the repeated pattern of injuries means short-term bandages may be the only option for weeks.
If the season turns on pitching depth, the Dodgers have already made their bet: push through with high turnover and hope the next arm holds. That bet is now more exposed. The single clear conclusion is this: until the team finds fewer injuries and more durable innings, roster churn will remain the story every time a shoulder flares or a starter is pulled early.
